Allegro Diagnostics

Maynard, United States Founded: 2006 • Age: 20 yrs Acquired By Veracyte
Genomic tests for lung cancer using next-generation sequencing were developed.
Request Access

About Allegro Diagnostics

Allegro Diagnostics is a company based in Maynard (United States) founded in 2006 was acquired by Veracyte in September 2014.. Allegro Diagnostics has raised $9.4 million across 4 funding rounds from investors including HHS, Veracyte and Boston University. Allegro Diagnostics operates in a competitive market with competitors including Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.

  • Headquarter Maynard, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $9.4 M (USD)

    in 4 rounds

  • Latest Funding Round
    $5.4 M (USD), Series A

    Jul 07, 2011

  • Investors
    HHS

    & 5 more

  • Employee Count
    Employee Count
  • Acquired by
    Veracyte

    (Sep 04, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Allegro Diagnostics

Allegro Diagnostics has successfully raised a total of $9.4M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $5.4 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $5.4M
  • First Round

    (07 Mar 2008)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2011 Amount Series A - Allegro Diagnostics Valuation Kodiak Venture Partners , CHV
Oct, 2009 Amount Grant - Allegro Diagnostics Valuation

investors

Sep, 2009 Amount Grant - Allegro Diagnostics Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Allegro Diagnostics

Allegro Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Veracyte and Boston University. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Seed and early stage venture fund investing in North America and Canada
Founded Year Domain Location
-
Founded Year Domain Location
Cancer research is conducted and supported by the institute.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Allegro Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Allegro Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Allegro Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Allegro Diagnostics

Allegro Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
domain founded_year HQ Location
Home-based genetic tests for detecting diseases are provided to individuals.
domain founded_year HQ Location
Genomic testing services are provided clinically and directly to consumers.
domain founded_year HQ Location
Molecular diagnostics and personalized medicine for cancer are developed.
domain founded_year HQ Location
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
domain founded_year HQ Location
Diagnostics and risk assessment solutions for lung cancer are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Allegro Diagnostics

Frequently Asked Questions about Allegro Diagnostics

When was Allegro Diagnostics founded?

Allegro Diagnostics was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Allegro Diagnostics located?

Allegro Diagnostics is headquartered in Maynard, United States. It is registered at Maynard, Massachusetts, United States.

Is Allegro Diagnostics a funded company?

Allegro Diagnostics is a funded company, having raised a total of $9.4M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2.93M, raised on Mar 07, 2008.

What does Allegro Diagnostics do?

Allegro Diagnostics was founded in 2006 in Maynard, United States, within the genomics and diagnostics sector. Focus was placed on developing tests for lung cancer, including the flagship BronchoGen assay. Next-generation sequencing was employed to assess inconclusive lung nodules from bronchoscopies, determining if they were cancerous or benign. The company was acquired by Veracyte in September 2014 for 21 million.

Who are the top competitors of Allegro Diagnostics?

Allegro Diagnostics's top competitors include Strand Life Sciences, Fulgent Genetics and Biodesix.

Who are Allegro Diagnostics's investors?

Allegro Diagnostics has 6 investors. Key investors include HHS, Veracyte, Boston University, National Cancer Institute, and Kodiak Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available